These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 24142576)
1. Management of peritoneal metastasis from neuroendocrine tumors. Au JT; Levine J; Aytaman A; Weber T; Serafini F J Surg Oncol; 2013 Nov; 108(6):385-6. PubMed ID: 24142576 [No Abstract] [Full Text] [Related]
2. [Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis]. Königsrainer I; Aschoff P; Zieker D; Beckert S; Glatzle J; Pfannenberg C; Miller S; Hartmann JT; Schroeder TH; Brücher BL; Königsrainer A Zentralbl Chir; 2008 Sep; 133(5):468-72. PubMed ID: 18924046 [TBL] [Abstract][Full Text] [Related]
3. [Peritoneal tumor pathology: case n(o) 2: a "sticky" peritoneal tumor]. Sabourin JC Ann Pathol; 2015 Aug; 35(4):321-6. PubMed ID: 26150276 [No Abstract] [Full Text] [Related]
4. Prevention and early treatment of peritoneal metastases from colorectal cancer: second-look laparotomy or prophylactic HIPEC? Baratti D; Kusamura S; Deraco M J Surg Oncol; 2014 Mar; 109(3):225-6. PubMed ID: 24452990 [No Abstract] [Full Text] [Related]
5. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy]. Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140 [TBL] [Abstract][Full Text] [Related]
6. Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy. Berthelot C; Morel O; Girault S; Verrièle V; Poirier AL; Moroch J; Boucher Y; Le Jeune JJ; Lorimier G Nucl Med Commun; 2011 Jan; 32(1):23-9. PubMed ID: 21042225 [TBL] [Abstract][Full Text] [Related]
7. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Pavel M; Baudin E; Couvelard A; Krenning E; Öberg K; Steinmüller T; Anlauf M; Wiedenmann B; Salazar R; Neuroendocrinology; 2012; 95(2):157-76. PubMed ID: 22262022 [No Abstract] [Full Text] [Related]
8. [Combined cytoreductive surgery and intraoperative hyperthermic chemo-perfusion for peritoneal carcinomatosis: methods, postoperative features and end results]. Tarasov VA; Vinogradova MV; Norbaev ShE; Sharov IuK; Stavrovietskiĭ VV; Adueva SA; Blium MB Vopr Onkol; 2006; 52(6):638-42. PubMed ID: 17338240 [TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery in the management of malignant ascites from adenocarcinoma of unknown primary (ACUP). Spurgeon JM; Cotlar AM Curr Surg; 2005; 62(5):500-3. PubMed ID: 16125606 [TBL] [Abstract][Full Text] [Related]
10. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results. Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814 [TBL] [Abstract][Full Text] [Related]
11. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer. Roviello F; Pinto E; Corso G; Pedrazzani C; Caruso S; Filippeschi M; Petrioli R; Marsili S; Mazzei MA; Marrelli D J Surg Oncol; 2010 Nov; 102(6):663-70. PubMed ID: 20721959 [TBL] [Abstract][Full Text] [Related]
12. [Lymph node metastasis removed, occult primary tumor. How to proceed?]. Füessl HS; Stiefelhagen P MMW Fortschr Med; 2012 Nov; 154(20):32. PubMed ID: 23234116 [No Abstract] [Full Text] [Related]
13. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant mixed mesodermal tumours with peritoneal dissemination. de Bree E; Romanos J; Relakis K; Tsiftsis DD Eur J Surg Oncol; 2005 Feb; 31(1):111-2. PubMed ID: 15642436 [No Abstract] [Full Text] [Related]
14. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer. Cascales Campos PA; Gil Martínez J; Galindo Fernández PJ; Gil Gómez E; Martínez Frutos IM; Parrilla Paricio P Eur J Surg Oncol; 2011 Jun; 37(6):543-8. PubMed ID: 21489742 [TBL] [Abstract][Full Text] [Related]
15. Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases. Bhosale P; Shah A; Wei W; Varadhachary G; Johnson V; Shah V; Kundra V Eur Radiol; 2013 Feb; 23(2):400-7. PubMed ID: 22932740 [TBL] [Abstract][Full Text] [Related]
16. Getting to the Root of the Problem. Wang J; Eng OS; Micic D Gastroenterology; 2020 Apr; 158(5):1229-1231. PubMed ID: 31560904 [No Abstract] [Full Text] [Related]
18. Neuroendocrine tumor of the gallbladder treated with neoadjuvant chemotherapy and surgery. Smith JL; Davis BR Am Surg; 2014 Mar; 80(3):318-20. PubMed ID: 24666880 [No Abstract] [Full Text] [Related]
20. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]